Cardiorentis Competitors and Similar CompaniesClear all
Cardiorentis's competitors and similar companies include Travere Therapeutics and Immunicum.
 Cardiorentis Cardiorentis is a biopharmaceutical company, developing drug therapies for the treatment of acute heart failure and related cardiovascular diseases. |  Travere Therapeutics Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases. |  Immunicum Immunicum is a biopharmaceutical company that develops immune therapies against a range of various tumors. | |
Founding Date | Founding Date N/A | Founding Date 2011 | Founding Date 2002 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Zug, CH HQ Freienbach, CH | Locations San Diego, US HQ Dublin, IE | Locations Stockholm, SE HQ Leiden, NL |
Employees | Employees N/A | Employees 46293% increase | Employees 28 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.4 b | Valuation ($) 49.3 m |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $490.7m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $10.3m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $480.4m (FY, 2025) | Gross profit kr7.8m (FY, 2025) |
Net income | Net income N/A | Net income ($25.5m) (FY, 2025) | Net income (kr113.3m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 118.5m | Total funding raised $ 25m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Travere Therapeutics
HQ
San Diego, US
Employees
462
Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases.
View companyImmunicum
HQ
Stockholm, SE
Employees
28
Immunicum is a biopharmaceutical company that develops immune therapies against a range of various tumors.
View company